Maine's Democratic governor wrote to the CMS that she's instead directing Maine's health and labor agencies to help prepare recipients of governmental assistance for work.
"We're buying a week at a time." It's Day 32 of the partial government shutdown, and a small rural hospital in New Mexico has seen its USDA loan dry up, threatening a pricey delay of a construction project.
This week the House committee chairs finalized their subcommittees and figured out who will be leading the healthcare policy charge in the lower chamber for the 116th Congress.
Senate health committee GOP Chair Lamar Alexander and top Democrat Patty Murray introduced five-year funding for community health centers and other key healthcare funding under the panel's jurisdiction.
New York currently ranks 30th in the country when it comes to maternal mortality rate. The state's executive budget calls for legislation to create a maternal mortality review board.
Medicare Payment Advisory Commission members say the panel needs to explore how to lower hospitals' drug prices covered under Medicare Part A, with some members floating binding arbitration as a possibility.
Arizona will suspend coverage for non-disabled Medicaid expansion enrollees who fail to report work activities for a single month.
Hundreds of groups including major healthcare industry associations and hospitals sent letters to Congress and President Donald Trump urging an end to the partial government shutdown, citing health consequences of the lapsed funding.
The Medicare Payment Advisory Commission recommended that Congress pass legislation to consolidate most of Medicare's value-based quality programs and boost payments for high-performing hospitals.
White House budget officials are weighing draft regulations to shape the VA's new, streamlined community care program that is poised to bring billions into private hospitals and clinics.
HHS Secretary Alex Azar said a proposal to tie prices for certain Medicare drugs to lower prices paid overseas is already paying dividends even though it hasn't formally been introduced yet.
Pharma critic Rep. Elijah Cummings is probing a dozen manufacturers over their drug pricing strategies and a bipartisan duo is calling for the FTC and Justice Department to come down on Bristol-Myers Squibb's acquisition of Celgene.